4//SEC Filing
Evans Thomas George 4
Accession 0001104659-21-061219
CIK 0001828185other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:23 PM ET
Size
8.0 KB
Accession
0001104659-21-061219
Insider Transaction Report
Form 4
Vaccitech plcVACC
Evans Thomas George
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2021-04-29+364,620→ 364,620 totalExercise: $17.00Exp: 2031-04-29→ Ordinary Shares (364,620 underlying) - Award
Share Option (Right to Buy)
2021-04-29+6,942→ 6,942 totalExercise: $17.00Exp: 2031-04-29→ Ordinary Shares (6,942 underlying)
Footnotes (3)
- [F1]This option shall vest and become exercisable on April 29, 2022.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F3]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022.
Documents
Issuer
Vaccitech plc
CIK 0001828185
Entity typeother
Related Parties
1- filerCIK 0001851686
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 8:23 PM ET
- Size
- 8.0 KB